179 related articles for article (PubMed ID: 35086209)
1. A comparative analysis of topical corticosteroids and non-steroidal anti-inflammatory drugs to control inflammation and macular edema following uneventful phacoemulsification.
Singhal D; Nanda A; Kanungo S; Sahoo K; Mohapatra S
Indian J Ophthalmol; 2022 Feb; 70(2):425-433. PubMed ID: 35086209
[TBL] [Abstract][Full Text] [Related]
2. Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac.
Wolf EJ; Braunstein A; Shih C; Braunstein RE
J Cataract Refract Surg; 2007 Sep; 33(9):1546-9. PubMed ID: 17720068
[TBL] [Abstract][Full Text] [Related]
3. Prospective, Randomized Study Comparing the Effect of 0.1% Nepafenac and 0.4% Ketorolac Tromethamine on Macular Thickness in Cataract Surgery Patients With Low Risk for Cystoid Macular Edema.
Ramakrishnan S; Baskaran P; Talwar B; Venkatesh R
Asia Pac J Ophthalmol (Phila); 2015; 4(4):216-20. PubMed ID: 26225780
[TBL] [Abstract][Full Text] [Related]
4. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
Sahu S; Ram J; Bansal R; Pandav SS; Gupta A
J Cataract Refract Surg; 2015 Oct; 41(10):2043-8. PubMed ID: 26703278
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory Medication of Cataract Surgery in Pseudoexfoliation Syndrome - NSAID Is Needed.
Ilveskoski L; Taipale C; Tuuminen R
Curr Eye Res; 2020 Jul; 45(7):814-819. PubMed ID: 31801388
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of addition of nepafenac 0.1% to steroid eye drops in prevention of post-phaco macular edema in high-risk eyes.
El Gharbawy SA; Darwish EA; Abu Eleinen KG; Osman MH
Eur J Ophthalmol; 2019 Jul; 29(4):453-457. PubMed ID: 30203671
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study.
Tzelikis PF; Vieira M; Hida WT; Motta AF; Nakano CT; Nakano EM; Alves MR
Br J Ophthalmol; 2015 May; 99(5):654-8. PubMed ID: 25385061
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.
Almeida DR; Khan Z; Xing L; Bakar SN; Rahim K; Urton T; El-Defrawy SR
J Cataract Refract Surg; 2012 Sep; 38(9):1537-43. PubMed ID: 22795976
[TBL] [Abstract][Full Text] [Related]
9. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
Miyake K; Ota I; Miyake G; Numaga J
J Cataract Refract Surg; 2011 Sep; 37(9):1581-8. PubMed ID: 21855758
[TBL] [Abstract][Full Text] [Related]
10. NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
Warren KA; Bahrani H; Fox JE
Retina; 2010 Feb; 30(2):260-6. PubMed ID: 20175270
[TBL] [Abstract][Full Text] [Related]
11. Intraindividual comparison of nepafenac 0.3% for the prevention of macular edema after phacoemulsification.
Tzelikis PF; Morato CS; Neves NT; Hida WT; Alves MR
J Cataract Refract Surg; 2018 Apr; 44(4):440-446. PubMed ID: 29685777
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis of macular edema after cataract surgery in diabetic patients, topical Nepafenac versus intravitreal Ranibizumab.
Howaidy A; Eldaly ZH; Anis M; Othman TM
Eur J Ophthalmol; 2022 Jan; 32(1):205-212. PubMed ID: 33726537
[TBL] [Abstract][Full Text] [Related]
13. Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery.
Zaczek A; Artzen D; Laurell CG; Stenevi U; Montan P
J Cataract Refract Surg; 2014 Sep; 40(9):1498-505. PubMed ID: 25135542
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of 0.1% Nepafenac versus 1% Prednisolone Acetate Eye Drops after Laser Peripheral Iridotomy: A Prospective, Randomized Trial.
Gayam K; Ramulu PY; Rengaraj V; Srinivasan K
Ophthalmol Glaucoma; 2020; 3(3):174-180. PubMed ID: 32672612
[TBL] [Abstract][Full Text] [Related]
15. Comparison of once daily dose of 0.3% nepafenac alone and three times dose of 0.1% nepafenac alone in pain and inflammation control after phacoemulsification.
Bardoloi N; Sarkar S; Burgute PS; Deb AK; Dholkawala R; Aggarwal P; Gokhale T
Indian J Ophthalmol; 2022 Mar; 70(3):807-812. PubMed ID: 35225519
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
Campa C; Salsini G; Perri P
Curr Eye Res; 2018 Mar; 43(3):362-367. PubMed ID: 29120255
[TBL] [Abstract][Full Text] [Related]
17. Incidence of cystoid macular edema following routine cataract surgery using NSAIDs alone or with corticosteroids.
Walter KA; Lee RY; Chen K; Komanski C
Arq Bras Oftalmol; 2020; 83(1):55-61. PubMed ID: 31664337
[TBL] [Abstract][Full Text] [Related]
18. Topical nonsteroidal anti-inflammatory drugs as adjuvant therapy in the prevention of macular edema after cataract surgery.
Cardascia N; Palmisano C; Centoducati T; Alessio G
Int Ophthalmol; 2017 Oct; 37(5):1127-1131. PubMed ID: 27766540
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting response of pseudophakic cystoid macular edema to topical steroids and nepafenac.
Sengupta S; Vasavada D; Pan U; Sindal M
Indian J Ophthalmol; 2018 Jun; 66(6):827-830. PubMed ID: 29785993
[TBL] [Abstract][Full Text] [Related]
20. Topical non-steroidal anti-inflammatory drugs for the treatment of cystoid macular edema post Descemet's stripping automated endothelial keratoplasty.
Kitazawa K; Kayukawa K; Wakimasu K; Inatomi T; Hieda O; Mori K; Sotozono C; Kinoshita S
Jpn J Ophthalmol; 2018 Nov; 62(6):615-620. PubMed ID: 30255396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
